# CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood

> **NCT04811846** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University Teaching Hospital Hall in Tirol** · enrollment: 40 (estimated)

## Conditions studied

- Urinary Bladder Neoplasm
- Transitional Cell Carcinoma
- Urogenital Neoplasms
- Circulating Tumor Cell
- Neoplasms

## Interventions

- **DEVICE:** Bipolar transurethral resection of bladder tumor (TURBT)
- **DEVICE:** Bipolar transurethral plasma kinetic vaporization of bladder tumor (PKVBT)

## Key facts

- **NCT ID:** NCT04811846
- **Lead sponsor:** University Teaching Hospital Hall in Tirol
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-14
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04811846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04811846, "CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04811846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*